富达MSCI医疗保健指数ETF FHLC 深 沪
等待开盘 08-11 09:30:00 美东时间
81.90
+1.230
+1.52%
华盛通- 最 高81.90
- 今 开80.60
- 成交量 14.81万股
- 最 低 80.60
- 昨 收 80.67
- 总市值 341.93万
- 52周最高 81.90
- 市盈率 静 --
- 换手率 354.61%
- 52周最低 63.536
- 委 比 35.57%
- 总股本 4.18万
- 历史最高 81.90
- 量 比 0.83
- 振 幅 1.61%
- 历史最低 15.491
- 每 手 1
- 风险率 4.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多High-flyer healthcare stocks: Ten names with strong momentum, weak valuations
Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price velocity against fu...
08-10 20:49
Biotech stocks lead healthcare's overbought list as earnings picks up
Healthcare stocks are in focus as second-quarter earnings season shifts into high gear, with investors evaluating whether recent rallies across biotech, medical technology and healthcare services can ...
07-23 19:18
Pharmaceuticals still a defensive play amid AI and geopolitical anxieties – analyst
Rajesh Kumar, head of European Life Sciences & Healthcare Equity Research at HSBC, positioned healthcare (XLV) as a defensive haven amid growing investor anxiety about AI investments and geopolitical ...
07-22 00:02
Citadel Securities: Market leadership broadens stumbles
Market leadership is showing clear signs of broadening, according to Citadel Securities’ Scott Rubner. Rather than exiting equities, investors are reallocating capital toward sectors that lagged in th...
07-13 23:13
Q2 watchlist: Healthcare stocks with perfect EPS revision scores
As Q2 2026 earnings season approaches, healthcare stocks are drawing investor attention as markets assess demand across care delivery, diagnostics, life sciences, pharmaceuticals, medical devices, and...
07-10 22:52
Biotech rally rests on fundamentals, M&A appetite, says ROTY's Faison
The recent rally in biotechnology stocks is being driven by improving fundamentals and a resurgence in merger activity rather than speculative excess, according to Jonathan Faison, founder of ROTY Bio...
07-09 16:33
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in June 2026
Short interest data from late June 2026 highlights deeply divided investor sentiment across the healthcare sector. Strong bearish bets remain heavily concentrated in speculative biotech plays like Rec...
07-01 22:20
JPMorgan bankers say Big Pharma M&A still outpaces biotech IPOs: report
Public markets are beginning to reopen for biotech companies after several years of muted activity. But the strongest companies may still be more likely to sell themselves to Big Pharma rather than te...
06-16 16:16
Citrini sees new upside in healthcare stocks, updates basket
Citrini Research has updated its healthcare basket as the firm grows increasingly bullish on a recovery in life sciences, bioprocessing, and healthcare infrastructure stocks driven by both cyclical im...
06-09 23:41
Beyond big tech: AI adoption spreads across nearly every sector
Artificial intelligence continues to dominate corporate conversations, with references to the technology on Russell 3000 earnings calls reaching a record 6,105 mentions in May. The total marked a 14% ...
06-08 23:40
